Revolution Medicines (RVMD) Return on Invested Capital (2020 - 2024)

Revolution Medicines' Return on Invested Capital history runs 5 years deep, the most recent figure standing at 0.0% for Q4 2024.

• In Q4 2024, Return on Invested Capital changed 0.0% year-over-year to 0.0%; the TTM figure through Dec 2024 stood at 0.0% (changed 0.0% YoY), while the FY2024 annual figure was 0.0%, changed 0.0% from the prior year.
• Return on Invested Capital was 0.0% for Q4 2024 at Revolution Medicines, up from 0.0% in the prior quarter.
• In the past five years, Return on Invested Capital ranged from a high of 0.0% in Q2 2021 to a low of 0.0% in Q3 2022.
• Historically, Return on Invested Capital has averaged 0.0% across 5 years, with a median of 0.0% in 2023.
• Biggest YoY gain for Return on Invested Capital was 0 bps in 2022; the steepest drop was 0 bps in 2022.
• A 5-year view of Return on Invested Capital shows it stood at 0.0% in 2020, then dropped by 14 bps to 0.0% in 2021, then plunged by 47 bps to 0.0% in 2022, then increased by 3 bps to 0.0% in 2023, then gained by 2 bps to 0.0% in 2024.
• The last three Return on Invested Capital figures came in at 0.0% (Q4 2024), 0.0% (Q3 2024), and 0.0% (Q2 2024), per Business Quant data.